• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺眼病的表型

Phenotypes of Thyroid Eye Disease.

作者信息

Uddin Jimmy M, Rubinstein Tal, Hamed-Azzam Shirin

机构信息

Moorfields Eye Hospital, Adnexal Service, London, United Kingdom.

出版信息

Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S28-S33. doi: 10.1097/IOP.0000000000001147.

DOI:10.1097/IOP.0000000000001147
PMID:29905636
Abstract

PURPOSE

To describe a new classification system of thyroid eye disease (TED) based on the phenotypic features (clinical and radiologic) of the disease.

METHODS

Clinical features, photographic, and orbital imaging of TED patients were considered in relation to their natural history and treatment response in the experience of the author. Phenotypically distinct categories of patients were identified and described.

RESULTS

Six phenotypes of TED are observed: 1) congestive (active inflammatory), 2) "white eye" expansion, 3) "hydraulic" apex, 4) "white eye" apex, 5) cicatricial active, and 6) cicatricial passive.

CONCLUSIONS

The observable characteristics of TED are determined by the underlying pathophysiology of the disease. TED is heterogeneous in its underlying pathogenesis, clinical manifestations, and response to medical and surgical treatment modalities. Several previous categorizations of the clinical appearance of TED exist, but they are dichotomous and underrepresent the heterogeneity of the disease. The authors present clinical and radiologic features of 6 different classes or phenotypes of TED and their response to different treatments.

摘要

目的

基于甲状腺眼病(TED)的表型特征(临床和放射学)描述一种新的分类系统。

方法

结合作者经验,考虑TED患者的临床特征、照片及眼眶成像与疾病自然史和治疗反应的关系。识别并描述表型不同的患者类别。

结果

观察到TED的六种表型:1)充血性(活动性炎症),2)“白眼”扩张,3)“液压性”眶尖,4)“白眼”眶尖,5)瘢痕性活动性,6)瘢痕性静止性。

结论

TED的可观察特征由疾病的潜在病理生理学决定。TED在其潜在发病机制、临床表现以及对药物和手术治疗方式的反应方面具有异质性。之前存在几种TED临床表现的分类,但都是二分法,未能充分体现该疾病的异质性。作者介绍了TED的6种不同类别或表型的临床和放射学特征及其对不同治疗的反应。

相似文献

1
Phenotypes of Thyroid Eye Disease.甲状腺眼病的表型
Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S28-S33. doi: 10.1097/IOP.0000000000001147.
2
Grading Severity and Activity in Thyroid Eye Disease.甲状腺眼病的严重程度和活动度分级
Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S34-S40. doi: 10.1097/IOP.0000000000001150.
3
Imaging Investigation of Thyroid Eye Disease.甲状腺眼病的影像学检查
Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S41-S51. doi: 10.1097/IOP.0000000000001139.
4
Radiologic Parameters of Orbital Bone Remodeling in Thyroid Eye Disease.甲状腺眼病眼眶骨重塑的放射学参数
Invest Ophthalmol Vis Sci. 2017 May 1;58(5):2527-2533. doi: 10.1167/iovs.16-21035.
5
Anatomic Considerations in Thyroid Eye Disease.甲状腺眼病的解剖学考量
Ophthalmic Plast Reconstr Surg. 2018 Jul/Aug;34(4S Suppl 1):S7-S12. doi: 10.1097/IOP.0000000000001122.
6
Evaluation of orbital soft tissue biomechanical parameters in patients with thyroid eye disease using the non-contact Corvis ST.应用非接触式 Corvis ST 评估甲状腺相关眼病患者的眼眶软组织生物力学参数
Int Ophthalmol. 2023 Oct;43(10):3615-3621. doi: 10.1007/s10792-023-02770-7. Epub 2023 Jul 2.
7
Age-Related Changes in the Clinical Phenotype of Compressive Optic Neuropathy in Thyroid Eye Disease.年龄相关性变化在甲状腺眼病压迫性视神经病变的临床表型。
Ophthalmic Plast Reconstr Surg. 2019 May/Jun;35(3):238-242. doi: 10.1097/IOP.0000000000001213.
8
Pathogenesis of thyroid eye disease--does autoimmunity against the TSH receptor explain all cases?甲状腺眼病的发病机制——抗 TSH 受体自身免疫能否解释所有病例?
Endokrynol Pol. 2010 Mar-Apr;61(2):222-7.
9
[Pathogenesis of thyroid eye disease - does autoimmunity against the TSH receptor explain all cases?].[甲状腺眼病的发病机制——针对促甲状腺激素受体的自身免疫能解释所有病例吗?]
Endokrynol Pol. 2011;62 Suppl 1:1-7.
10
Occult thyroid eye disease in patients with unexplained ocular misalignment identified by standardized orbital echography.通过标准化眼眶超声检查在不明原因眼球偏斜患者中发现隐匿性甲状腺眼病。
Am J Ophthalmol. 2006 Jul;142(1):75-81. doi: 10.1016/j.ajo.2006.01.089.

引用本文的文献

1
Predictive demographic and clinical features for the development of dysthyroid optic neuropathy in a multi-ethnic TED population: a retrospective cohort study.多民族甲状腺相关眼病患者发生甲状腺功能障碍性视神经病变的预测性人口统计学和临床特征:一项回顾性队列研究
Thyroid Res. 2025 Jul 22;18(1):37. doi: 10.1186/s13044-025-00249-4.
2
The Use of Biologics for Thyroid Eye Disease.生物制剂在甲状腺眼病中的应用。
BioDrugs. 2025 Jun 6. doi: 10.1007/s40259-025-00726-0.
3
Radiological Activity Score (RAS)-MRI Characteristics in Dysthyroid Optic Neuropathy in a Multi-Ethnic Thyroid Eye Disease Population.
多民族甲状腺眼病患者甲状腺功能异常性视神经病变的放射学活动评分(RAS)-MRI特征
Clin Endocrinol (Oxf). 2025 Sep;103(3):385-395. doi: 10.1111/cen.15272. Epub 2025 May 20.
4
The burden of illness in thyroid eye disease: current state of the evidence.甲状腺眼病的疾病负担:证据现状
Front Ophthalmol (Lausanne). 2025 Apr 17;5:1565762. doi: 10.3389/fopht.2025.1565762. eCollection 2025.
5
Optical coherence tomography angiography in thyroid associated ophthalmopathy: a systematic review.光学相干断层扫描血管造影在甲状腺相关眼病中的应用:系统评价。
BMC Ophthalmol. 2024 Jul 22;24(1):304. doi: 10.1186/s12886-024-03569-5.
6
Thyroid Eye Disease and its Vision-Threatening Manifestations in the Academy IRIS Registry: 2014-2018.甲状腺眼病及其在 Academy IRIS 注册研究中的威胁视力表现:2014-2018 年。
Am J Ophthalmol. 2023 Sep;253:74-85. doi: 10.1016/j.ajo.2023.04.013. Epub 2023 May 17.
7
Teprotumumab (Tepezza) for Thyroid Eye Disease.特普替尼单抗(特泽扎)治疗甲状腺眼病。
Mo Med. 2022 Jan-Feb;119(1):36-41.
8
Imaging of the medial rectus muscle predicts the development of optic neuropathy in thyroid eye disease.内直肌成像可预测甲状腺眼病视神经病变的发展。
Sci Rep. 2022 Apr 15;12(1):6259. doi: 10.1038/s41598-022-10043-z.
9
18 F-FDG-PET/MRI in patients with Graves' orbitopathy.18 F-FDG-PET/MRI 在 Graves 眼病患者中的应用。
Graefes Arch Clin Exp Ophthalmol. 2021 Oct;259(10):3107-3117. doi: 10.1007/s00417-021-05339-1. Epub 2021 Aug 18.